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Spina bifida is one of the most prevalent major birth malformations with a worldwide 
incidence of approximately 1:2,000 live births1. A myelomeningocele (MMC) is the most 
frequent form of spina bifida, characterized by the extrusion of the spinal cord and/or 
nerves through a bony defect of the spine into a sac filled with cerebrospinal fluid (CSF). 
The severity of symptoms is correlated with the level of the defect. Interruption of the 
spinal cord at the site of the defect can cause lifelong paralysis of the legs, bowel and blad-
der dysfunction, sensibility disorders of the skin, sexual dysfunction and deformation of 
the lower extremities and back. Most children with spina bifida are not mentally retarded, 
but their intelligence quotient can be reduced2,3. Although spina bifida can be compatible 
with independent life, lifelong supportive care is often needed, and only about half of the 
patients are able to live independently as adults, even with adapted accommodations3,4. 
The majority of children with spina bifida have a Chiari II malformation, which is a com-
bination of hindbrain herniation and hydrocephalus4, and is the leading cause of death in 
patients with spina bifida5. In 45% of the fetuses with spina bifida registered within the 
Dutch registration of Eurocat, the parents decided to terminate pregnancy after prenatal 
diagnosis. This is consistent with numbers from the USA; however, in some areas of the 
Netherlands, these figures are considerably higher2.
With the introduction of the routine second trimester ultrasound scan, the number of 
prenatal diagnosis of spina bifida increased considerably. The classical prenatal ultrasound find-
ings in spina bifida are typical U-shaped defect of the vertebral column in an open spina bifida, 
typical lemon shape of the fetal skull and banana shape of cerebellum. The ventriculomegaly 
occurs in the majority of cases, and club feet are also present in several cases6. The current 
standard of postnatal care is neurosurgical closure of the defect within 48 to 72 hours after 
birth. However, surgical intervention does not improve neurological function, but prevents 
further deterioration7. After birth, 80 to 90% of children with hydrocephalys will receive a 
ventriculo-peritoneal shunt placement to prevent additional damage to brain and brainstem8. 
Despite the successes of postnatal neurosurgical repair and medical treatment of spina bifida, 
mortality still remains approximately 10%, rising to 35% in those children with symptoms 
of brainstem dysfunction secondary to the Chiari II malformation. 
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The question whether the neurological disorders as-
sociated with spina bifida are caused by either a primary 
disorder of neurulation during the embryonic development 
of the spinal cord, or by secondary damage to a primarily 
normal spinal cord caused by the intrauterine environment, 
or both, has been studied and described extensively in the 
literature9,10. This knowledge led to the “two-hit” hypoth-
esis: failure of primary neurulation in the embryonic period 
leads to the development of myelodysplasia (first-hit), and, 
due to the absence of skin and musculoskeletal coverage, 
the persistent exposure of the openly exposed neural tissue 
to the intrauterine environment can lead to secondary ac-
quired neural tissue damage and, consequently, irreversible 
loss of neurological function (second-hit)11,12. Experiments 
suggest that late gestation amniotic fluid might be toxic to 
the exposed neural tissue and can cause chemical injury13. 
Destruction can also be caused by mechanical shearing and 
abrasive stresses on the surface of the delicate neural tissue, 
especially in the third trimester, when there is increasingly 
less amniotic fluid11.
This “two-hit” hypothesis is the rationale for in utero 
repair of a spina bifida, implicating that the second hit 
can be prevented by intrauterine closure of the defect12. 
Prenatal coverage would stop the progressive neural tis-
sue destruction and improve the neurological outcome 
at birth14. Also, in utero coverage of the defect may stop 
the leakage of CSF and consequently have a positive ef-
fect on the associated cerebral anomalies like hindbrain 
herniation and hydrocephalus15.
The first intrauterine MMC repairs were performed 
in mid-1990s using the endoscopic technique in the 
Vanderbilt University Medical Center, Nashville, Tennessee, 
USA; however, the technique was abandoned because of 
bad outcomes16. The first open surgeries for intrauterine 
treatment of MMC were performed in the end-1990s, and 
the outcome of children after prenatal surgery showed 
decreased rate of ventriculo-peritoneal shunt placement 
and reversion of brainstem herniation when compared with 
postnatal surgery17,18. However, the rates of complications 
as preterm labor, premature rupture of membranes, preterm 
delivery, choriomnionites, uterine dehiscence and perinatal 
deaths still were considerable19,20. Because of controversies 
between benefits versus risks of intrauterine MMC repair, 
a randomized controlled trial, named Management of 
Myelomeningocele Study (MOMS), was developed between 
2003 and 2008 in three American centers (University of 
California, The Children’s Hospital of Philadelphia and 
Vanderbilt University Medical Center). This trial pro-
posed to randomize 200 pregnant women, being 100 to 
intrauterine repair and 100 to postnatal surgery. The trial 
stopped after the recruitment of 183 patients, because of 
the benefits of intrauterine surgery. Intrauterine MMC 
repair reduced the rate of ventriculo-peritoneal shunt 
placement, showed improvements in a composite score for 
mental development and motor function at 30 months and 
improvements in several secondary outcomes, including 
hindbrain herniation by 12 months and ambulation by 
30 months. However, open surgery was still associated 
with maternal and fetal risks, mainly uterine dehiscence 
and preterm deliveries21. After this trial, the participating 
centers published their own post-MOMS trial experience 
with better outcomes, mainly in uterine dehiscence and 
premature rupture of membranes rates22,23. From other 
centers in the world, only limited data is available with 
small numbers of cases24,25.
In 2000s, the endoscopic technique was restarted 
in two centers, one in Germany and one in Brazil26,27. 
The first cases were published recently, however not within 
a randomized controlled trial to prove its real benefits. 
Compared to open surgery, the endoscopic technique takes 
a longer duration time of surgery and has a higher rate of 
premature rupture of membranes. In some cases, a second 
surgery is necessary after birth to correct the spinal defect. 
Especially with large defects primarily, tension-free, in 
utero closure with skin is sometimes not possible28. 
Because of the present outcomes after endoscopic 
surgery and also the high rate of premature rupture of 
membranes and preterm labor, further research is war-
ranted. Single port access with an endoscope of 3.0 mm 
or less and covering the defect using smart tissue engi-
neering techniques might decrease the complication rate 
and allow normal delivery instead of cesarean section. 
Tissue engineered constructs or glues need to be tailored, 
especially to the needs of surgical reconstruction of birth 
defects in the fetal period, particular when looking at the 
prerequisites of fetal MMC surgery.
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